Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onn Min Kon

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Thorax|January 4, 2014
Time for a preventative strategy for TB in the UK: further evidence for new entrant screening in primary careOnn Min Kon
Microorganisms|November 27, 2021
Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary DiseaseKartik Kumar, Onn Min Kon
Expert Review of Anti-Infective Therapy|August 19, 2020
Use of Xpert MTB/RIF and Xpert Ultra in extrapulmonary tuberculosisMirae Park, Onn Min Kon
Thorax|February 5, 2015
The national TB strategy: jointly taking responsibility for TB control?Onn Min Kon, Lawrence Peter Ormerod
The Journal of Infection|March 21, 2014
GeneXpert(®) MTB/RIF in low prevalence settings: a UK laboratory perspectiveAnika Singanayagam, Hugo Donaldson, Onn Min Kon
Clinical Medicine (London, England)|March 16, 2019
An update on multidrug-resistant tuberculosis Mirae Park, Giovanni Satta, Onn Min Kon
Lancet (London, England)|August 30, 2025
Why are we failing to rapidly diagnose tuberculosis in the UK?Francis Drobniewski, Onn Min Kon, Ximena Gonzalo, et al.
BMJ Case Reports|March 5, 2021
When to consider tuberculosis: bronchiectasis in the elderly populationCaitlin Rose Morgan, Georgina K Russell, Onn Min Kon
BMC Infectious Diseases|April 8, 2022
Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistanceMirae Park, Ajit Lalvani, Giovanni Satta, et al.
BMJ Case Reports|January 19, 2021
CA 125 and TBMirae Park, Ranju Dhawan, Elizabeth Whittaker, et al.
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Thorax|January 4, 2014
Time for a preventative strategy for TB in the UK: further evidence for new entrant screening in primary careOnn Min Kon
Microorganisms|November 27, 2021
Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary DiseaseKartik Kumar, Onn Min Kon
Expert Review of Anti-Infective Therapy|August 19, 2020
Use of Xpert MTB/RIF and Xpert Ultra in extrapulmonary tuberculosisMirae Park, Onn Min Kon
Thorax|February 5, 2015
The national TB strategy: jointly taking responsibility for TB control?Onn Min Kon, Lawrence Peter Ormerod
The Journal of Infection|March 21, 2014
GeneXpert(®) MTB/RIF in low prevalence settings: a UK laboratory perspectiveAnika Singanayagam, Hugo Donaldson, Onn Min Kon
Clinical Medicine (London, England)|March 16, 2019
An update on multidrug-resistant tuberculosis Mirae Park, Giovanni Satta, Onn Min Kon
Lancet (London, England)|August 30, 2025
Why are we failing to rapidly diagnose tuberculosis in the UK?Francis Drobniewski, Onn Min Kon, Ximena Gonzalo, et al.
BMJ Case Reports|March 5, 2021
When to consider tuberculosis: bronchiectasis in the elderly populationCaitlin Rose Morgan, Georgina K Russell, Onn Min Kon
BMC Infectious Diseases|April 8, 2022
Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistanceMirae Park, Ajit Lalvani, Giovanni Satta, et al.
BMJ Case Reports|January 19, 2021
CA 125 and TBMirae Park, Ranju Dhawan, Elizabeth Whittaker, et al.
Pageof 15